Drawing for SYREMIS THERAPEUTICS

USPTO serial 79445721

SYREMIS THERAPEUTICS

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
GUZICK, LEAH A
Law office
TMO LAW OFFICE 136

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SYREMIS THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Neil A. Salyards

Neil A. Salyards Procopio, Cory, Hargreaves & Savitch LLP525 B Street, Suite 2200San Diego, CA 92101United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medical preparations for the treatment of psychiatric, central nervous system, gastrointestinal, hepatic, biliary, immunological, allergic, inflammatory, metabolic, autoimmune and neurological diseases and disorders; pharmaceutical preparations for the relief of pain being anesthesia; pharmaceutical, vegetal being medicinal herbal, medicinal herbal, and natural pharmaceutical preparations and substances for the treatment of anxiety and depression; vitamins; minerals as food supplements; food supplements; nutritional supplements; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system, gastrointestinal, hepatic, biliary, immunological, allergic, inflammatory, metabolic, autoimmune, neurological, psychiatric and pediatric diseases and disorders; diagnostic preparations for medical use; diagnostic reagents for medicinal use; veterinary preparations, namely, pain relief medication; medicated gels, creams and lubricantsACTIVE—
035Retail and wholesale services, namely, retail and wholesale stores featuring pharmaceutical preparations, medicines, medical, surgical and dental apparatus and instruments, nutritional supplements, vitamins, mineral supplements; business management services, namely, administration of business engaged in the field of pharmaceutical preparations and medical products; providing office functions; import agency services in the field of pharmaceutical preparations and medical products; sales promotion services; business consulting services; business information services; public relations services; electronic commerce services, namely, providing information about products via telecommunication networks for advertising and sales purposes; purchase and rental of advertising space; direct mail advertising; business networking; arranging of business introductions being special events; advertising, marketing and promotional services relating to pharmaceuticals and medical products; marketing and promotion of pharmaceutical preparations and medical products; market research services relating to pharmaceuticals and medical products; conducting business surveys and the collection of data relating to pharmaceuticals, medical products and medical activities for business purposes; commercial information and consumer product advice relating to pharmaceuticals, medical products and medical information; organization of trade and commercial conferences and conventions relating to pharmaceuticals and medical products; distribution of samples; price comparison services and coupon procurement services for others in the field of pharmaceuticals and medical productsACTIVE—
041Organization of business conferences and conventions relating to pharmaceuticals and medical products; education services, namely, training educators in the field of pharmaceutical preparations and medical productsACTIVE—
042Research services in the field of pharmaceuticals and medical products; scientific research and technological consulting services in the field of product development in the field of pharmaceuticals; scientific research and technological consulting services in the field of design and product development in the field of pharmaceuticals; industrial analysis being consulting services in the field of design and product development of pharmaceuticals and medical products; industrial research being consulting and research services in the field of design and product development of pharmaceuticals and medical products; industrial design and development services being consulting, analysis and material testing services in the field of pharmaceuticals and medical products; design and development of artificial intelligence and machine learning software for use in the field of pharmaceuticals and medical products; design and development of products in the field of pharmaceuticals; development and design services relating to pharmaceutical preparations and medical products; molecule discovery services for use in the development of pharmaceuticals being drug discovery services.ACTIVE—
044Medical services; veterinary services; hygienic and beauty care for human beings and animalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 18, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 18, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 18, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 6, 2026RFNTREFUSAL PROCESSED BY IB—
Jul 23, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 23, 2026RFRRREFUSAL PROCESSED BY MPU—
Jun 5, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 4, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2026DOCKASSIGNED TO EXAMINER—
Mar 13, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 13, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 12, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance